UCL Innovation Forum – London – 24th April 2018

TECL’s CEO Ann Kramer will be speaking at this year’s Innovation Forum event on Regenerative Medicine. A new era in Regenerative Medicine: accelerating research from bench to bedside. You can register here. About the event Stem Cell Therapies, CAR-T, Cell and Gene Therapies, are the cutting-edge technologies of translational medicine in the 21st century. They… Read more »

Melt electrospinning arrives at The Electrospinning Company

Part of the BONE project, The Electrospinning Company will be playing a crucial role in translating academic findings using melt electrospinning into clinical-grade products. We are extremely excited to have finally received our melt electrospinning device, work together with our BONE partners towards novel medical devices and expanding our expertise in electrospinning. the Electrospinning Team

ISO 13485:2016 QMS recertification

The Electrospinning Company has updated its Quality Management System to the new ISO 13485:2016 standard for the design, development, manufacture and supply of electrospun polymer scaffolds, and has been re-certified for a further three years. The ISO13485 standard has been updated from 13485:2003 to 13485:2016 to keep up with changes in the medical device industry… Read more »

Biotrinity – London – April 24th 2018

BioTrinity is Europe’s Leading Biopartnering and Investment Conference and is in London from April 23-25 2018   Ann Kramer will be on a panel ‘The Future of Medical 3D Printing’ session at BioTrinity 2018, that is taking place on Tuesday, 24 April at 13:40 – 14:30.  

Materials Research Exchange – London – 13th March 2018

Ann Kramer will be at The Materials Research Exchange event at the Design Centre, Islington, London on 13th March. The 2018 Materials Research Exchange Conference and Exhibition will showcase the richness of UK materials research and innovation providing an ideal opportunity to absorb current trends and take a glimpse of future innovations.  

Biomaterials Risk Management BIORIMA H2020 grant

The Electrospinning Company is a partner in the EU funded H2020 Research and Innovation action BIORIMA (Biomaterial Risk Management). The project aims to develop an integrated risk management framework for nano-biomaterials used in advanced therapeutic medicinal products and medical devices. The BIORIMA risk management framework is a structure upon which the validated tools and methods… Read more »

MeDe Innovation – Sheffield, UK – 18 Jan 2018

Marco Thio will be at the MeDe Innovation 5th Annual Conference.  The conference brings together MeDe Innovation’s network of academics, industrialists, clinicians and regulatory body representatives through lively presentations, debate and poster sessions. It is a unique opportunity to access the latest developments in orthopaedic medical device manufacture. Selina Beal (@SN_Beal) from the University of… Read more »